LDDD.US Longduoduo Company Limited

Healthcare Biotechnology USA Stocks
0.5100 USD
Close of Nov 3, 2026
0.5100 0.9340
Market cap
USD 15.3M
P/E
-
P/B
21.75x
ROE
-82.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is LDDD.US undervalued?

Graham number

The Graham number of Longduoduo Company Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Longduoduo Company Limited fundamental analysis

No fundamental analysis for Longduoduo Company Limited yet.

Longduoduo Company Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Longduoduo Company Limited

Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, gastrointestinal digestive disorders, and cardiovascular and cerebrovascular diseases through third-party healthcare s…

Full company profile